Breaking News
Close
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

GSK plc (GSKl)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1,745.97 +33.60    +1.95%
24/06 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 3,926,954
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1,729.60 - 1,756.29
Type:  Equity
Market:  Euro Zone
ISIN:  GB0009252882 
GSK plc 1,745.97 +33.60 +1.95%
  • General    
  • Chart    
  • News & Analysis    
  • Financials    
  • Technical    
  • Forum    
  • InvestingPro

GSKl Income Statement

 
Assess the Glaxo income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Collapse All
Period Ending: 2022
31/03
 2021
31/12
 2021
30/09
 2021
30/06
Total Revenue 9780 9527 9077 8092
Revenue 9780 9527 9077 8092
Other Revenue, Total - - - -
Cost of Revenue, Total 3645 3675 2822 2519
Gross Profit 6135 5852 6255 5573
Total Operating Expenses 6979 8632 7139 6453
Selling/General/Admin. Expenses, Total 2681 2908 2504 2498
Research & Development 1154 1363 1169 1165
Depreciation / Amortization 23 25 25 25
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) -385 796 735 323
Other Operating Expenses, Total -139 -135 -116 -77
Operating Income 2801 895 1938 1639
Interest Income (Expense), Net Non-Operating -203 -189 -190 -169
Gain (Loss) on Sale of Assets - - - -36
Other, Net - - - -
Net Income Before Taxes 2598 706 1748 1470
Provision for Income Taxes 431 -224 380 -68
Net Income After Taxes 2167 930 1368 1538
Minority Interest -365 -181 -200 -143
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1802 749 1168 1395
Total Extraordinary Items - - - -
Net Income 1802 749 1168 1395
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1802 749 1168 1395
Dilution Adjustment - - - -
Diluted Net Income 1802 749 1168 1395
Diluted Weighted Average Shares 5068 5074 5060 5060
Diluted EPS Excluding Extraordinary Items 0.36 0.15 0.23 0.28
DPS - Common Stock Primary Issue 0.14 0.23 0.19 0.19
Diluted Normalized EPS 0.27 0.23 0.34 0.25
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GSK Comments

Write your thoughts about Glaxosmithkline
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Anon Anon
Anon Anon Jan 17, 2022 11:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
Reply
2 2
Report
Anon Anon
Anon Anon Dec 09, 2021 8:46
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
Reply
5 3
Report
Will Strath
Will Strath Nov 05, 2021 12:52
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ex-div in 13 days time. why risk selling now when you might not get back on the boat? pretty sure the company split will reach equivalent of 2000+ for the two new companies.
Reply
5 1
Report
Craig Nelson
Craig Nelson Nov 05, 2021 9:14
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1587.80 looking at my previous comment "what do i know" near yearly HIGHS
Reply
0 0
Report
Anon Anon
Anon Anon Nov 01, 2021 8:16
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Breakout. Strong buy
Reply
1 0
Report
Craig Nelson
Craig Nelson Oct 16, 2021 18:25
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1399.60p described as a good Divi stock but where's the potential capital growth... will wait for sub 1200.00p
Reply
1 2
Report
Robin Mitha
Robin Mitha Jun 23, 2021 12:55
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The current CEO seems to have lost confidence, time for a change to inject new life into the company
Reply
0 6
Report
simon stirling
simon stirling Jun 23, 2021 12:55
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
the news from today remarked that investors present applauded during the event.
Reply
0 0
Report
Robin Mitha
Robin Mitha Jun 23, 2021 12:55
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
the question is what percentage of GSK shareholders attended, most big investors gont go to such events
Reply
1 0
Report
simon stirling
simon stirling Jun 23, 2021 12:55
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
while true, until we know who attended it's hard to gauge lost confidence. at the start of the day pre share holder day, the share price was 20p down, that swung to 40p up at one point, hardly signals negativity
Reply
4 0
Report
STEPHEN CLARKE
Engweliri Jun 11, 2021 13:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Seems to me that a stake is being built, especially from the area of £13.25 upwards. We already have the "activist" investment fund but another buyer is around. Seems similar to whats been happening in BT shares over the last few weeks. Stay long and collect dividends on the way. Hopefully
Reply
3 1
Report
Mo Ahmadi
Mo Ahmadi Jun 11, 2021 13:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what will happen when the split happens in 2022?!
Reply
1 0
Report
Mithan India
Mithan India May 08, 2021 20:14
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
MINAYULSK
Reply
0 0
Report
Craig Nelson
Craig Nelson May 02, 2021 23:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There is absolutely value at its 12m lows 1190.00 so I'm waiting for any bad news and will buy in the dips.... Are THEY PAYING A Dividend???
Reply
1 3
Report
Paul Whitling
Paul Whitling May 02, 2021 23:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yes, 23p per share last time round in April
Reply
1 0
Report
simon stirling
simon stirling May 02, 2021 23:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I believe the next dividend, may 20th, is 19p.
Reply
1 0
Report
Craig Nelson
Craig Nelson May 02, 2021 23:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
thanks Paul , Simon.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Investing.com
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email